McCulloch Michael, Jezierski Tadeusz, Broffman Michael, Hubbard Alan, Turner Kirk, Janecki Teresa
Pine Street Foundation, San Anselmo, California 94960, USA.
Integr Cancer Ther. 2006 Mar;5(1):30-9. doi: 10.1177/1534735405285096.
Lung and breast cancers are leading causes of cancer death worldwide. Prior exploratory work has shown that patterns of biochemical markers have been found in the exhaled breath of patients with lung and breast cancers that are distinguishable from those of controls. However, chemical analysis of exhaled breath has not shown suitability for individual clinical diagnosis.
The authors used a food reward-based method of training 5 ordinary household dogs to distinguish, by scent alone, exhaled breath samples of 55 lung and 31 breast cancer patients from those of 83 healthy controls. A correct indication of cancer samples by the dogs was sitting/lying in front of the sample. A correct response to control samples was to ignore the sample. The authors first trained the dogs in a 3-phase sequential process with gradually increasing levels of challenge. Once trained, the dogs' ability to distinguish cancer patients from controls was then tested using breath samples from subjects not previously encountered by the dogs. The researchers blinded both dog handlers and experimental observers to the identity of breath samples. The diagnostic accuracy data reported were obtained solely from the dogs' sniffing, in double-blinded conditions, of these breath samples obtained from subjects not previously encountered by the dogs during the training period.
Among lung cancer patients and controls, overall sensitivity of canine scent detection compared to biopsy-confirmed conventional diagnosis was 0.99 (95% confidence interval [CI], 0.99, 1.00) and overall specificity 0.99 (95% CI, 0.96, 1.00). Among breast cancer patients and controls, sensitivity was 0.88 (95% CI, 0.75, 1.00) and specificity 0.98 (95% CI, 0.90, 0.99). Sensitivity and specificity were remarkably similar across all 4 stages of both diseases.
Training was efficient and cancer identification was accurate; in a matter of weeks, ordinary household dogs with only basic behavioral "puppy training" were trained to accurately distinguish breath samples of lung and breast cancer patients from those of controls. This pilot work using canine scent detection demonstrates the validity of using a biological system to examine exhaled breath in the diagnostic identification of lung and breast cancers. Future work should closely examine the chemistry of exhaled breath to identify which chemical compounds can most accurately identify the presence of cancer.
肺癌和乳腺癌是全球癌症死亡的主要原因。先前的探索性研究表明,在肺癌和乳腺癌患者的呼出气体中发现了生化标志物模式,这些模式与对照组不同。然而,呼出气体的化学分析尚未显示出适用于个体临床诊断。
作者采用基于食物奖励的方法训练5只普通家犬,仅通过气味区分55名肺癌患者和31名乳腺癌患者的呼出气体样本与83名健康对照者的样本。犬对癌症样本的正确指示是坐在/躺在样本前。对对照样本的正确反应是忽略该样本。作者首先通过三个阶段的连续过程训练犬,挑战水平逐渐增加。一旦训练完成,然后使用犬之前未接触过的受试者的呼出气体样本测试犬区分癌症患者和对照者的能力。研究人员对犬的训练者和实验观察者隐瞒呼出气体样本的身份。报告的诊断准确性数据仅来自犬在双盲条件下对这些在训练期间未接触过的受试者的呼出气体样本的嗅闻。
在肺癌患者和对照者中,与活检确诊的传统诊断相比,犬嗅觉检测的总体敏感性为0.99(95%置信区间[CI],0.99,1.00),总体特异性为0.99(95%CI,0.96,1.00)。在乳腺癌患者和对照者中,敏感性为0.88(95%CI,0.75,1.00),特异性为0.98(95%CI,0.90,0.99)。两种疾病的所有4个阶段的敏感性和特异性都非常相似。
训练有效且癌症识别准确;在几周内,仅经过基本行为“幼犬训练”的普通家犬就被训练能够准确区分肺癌和乳腺癌患者的呼出气体样本与对照者的样本。这项使用犬嗅觉检测的试点工作证明了使用生物系统检查呼出气体在肺癌和乳腺癌诊断识别中的有效性。未来的工作应密切研究呼出气体的化学成分,以确定哪些化合物能够最准确地识别癌症的存在。